26 October 2017
UK Chancellor of the Exchequer Philip Hammond has announced a new £17m life sciences funding, which is intended to aid the discovery of new drugs and support treatment for mental...
25 October 2017
A new study by researchers at the University of Strathclyde, UK, is set to investigate a new method of enhancing brain activity for the prevention of Alzheimer’s disease.
9 October 2017
Researchers from the University of California (UC) have collaborated with affiliated national laboratory scientists and industry experts to use advanced supercomputing capabilities for the development of new and personalised cancer...
3 October 2017
Transgene has a partnered with in-vitro diagnostics company Randox to combine their technologies and develop multifunctional oncolytic immunotherapies.
24 September 2017
Austrian start-up OncoQR ML has confirmed that a single therapeutic vaccine based on its Specific Total Immune Remodeler (S-TIR) platform is capable of simultaneously inducing and activating the killing of...
21 September 2017
GSK has joined forces with AstraZeneca and Labcyte to combine acoustic liquid dispensing technology with mass spectrometry (MS) for use in high throughput small molecule screening and other drug discovery...
10 September 2017
Science and technology company Merck and Project Data Sphere are set to collaborate to jointly lead the Global Oncology Big Data Alliance (GOBDA).
5 July 2017
England’s chief medical officer professor Dame Sally Davies has highlighted the need for routine access to genetic testing to improve diagnosis and treatment of cancer in the UK.
5 June 2017
Novartis has partnered with IBM Watson Health on an outcome-based initiative for patients with advanced breast cancer.
22 May 2017
Singapore eDevelopment subsidiary Global BioLife has started advanced research on a new universal therapeutic drug platform called Linebacker to tackle multiple conditions such as Alzheimer's, diabetes, and cancer.